Efficacy of AZT therapy in reducing p24 antigen burden in a modified SCID mouse model of HIV infection
- 31 May 1995
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 27 (1-2) , 85-97
- https://doi.org/10.1016/0166-3542(94)00079-n
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effect of 2',3'-didehydro-3'-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studiesAntimicrobial Agents and Chemotherapy, 1994
- Efficacy of ganciclovir in combination with other antimicrobial agents against cytomegalovirus in vitro and in vivoAntiviral Research, 1993
- Efficacy of oral treatment with BV-araU against cutaneous infection with herpes simplex type 1 in shaved miceAntiviral Research, 1992
- Human non-Hodgkin's malignant lymphomas serially transplanted in nude mice conditioned with whole-body irradiationBritish Journal of Cancer, 1989
- Development of Disease and Virus Recovery in Transgenic Mice Containing HIV Proviral DNAScience, 1988
- Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trialArchives of internal medicine (1960), 1988
- Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animalsAntimicrobial Agents and Chemotherapy, 1988
- Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseasesClinical Pharmacology & Therapeutics, 1987
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Treatment of Experimental Herpesvirus Infections with Phosphonoformate and Some Comparisons with PhosphonoacetateAntimicrobial Agents and Chemotherapy, 1978